Literature DB >> 23702423

Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats.

Maimaiti Yisireyili1, Hidehisa Shimizu, Shinichi Saito, Atsushi Enomoto, Fuyuhiko Nishijima, Toshimitsu Niwa.   

Abstract

AIMS: Cardiovascular disease (CVD) is common in chronic kidney disease (CKD) patients. Indoxyl sulfate (IS) is a nephrovascular uremic toxin that induces oxidative stress in kidney and vascular system. The present study aimed to examine the effect of IS on fibrosis and oxidative stress in rat heart. MAIN
METHODS: The effects of IS on heart were examined by Masson's trichrome (MT) staining and immunohistochemistry using: (1) Dahl salt-resistant normotensive rats (DN), (2) Dahl salt-resistant normotensive IS-administered rats (DN+IS), (3) Dahl salt-sensitive hypertensive rats (DH), and (4) Dahl salt-sensitive hypertensive IS-administered rats (DH+IS). KEY
FINDINGS: DH+IS rats showed significantly increased heart weight and left ventricle weight compared with DN. DH and DH+IS rats showed significantly increased diameter of cardiomyocytes, increased MT-positive fibrotic area, increased staining for transforming growth factor (TGF)-β1, α-smooth muscle actin (SMA), type 1 collagen, NADPH oxidase Nox 4, malondialdehyde (MDA), and 8-hydroxydeoxyguanosine (8-OHdG) and decreased staining for nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and heme oxygenase-1 (HO-1) in the heart compared with DN. More notably, DH+IS rats showed significantly increased diameter of cardiomyocytes, increased fibrotic area, increased staining for TGF-β1, SMA, type 1 collagen, Nox4, 8-OHdG and MDA, and decreased staining for Nrf2 and HO-1 in the heart compared with DH. SIGNIFICANCE: IS aggravates cardiac fibrosis and cardiomyocyte hypertrophy with enhanced oxidative stress and reduced anti-oxidative defense in hypertensive rats.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23702423     DOI: 10.1016/j.lfs.2013.05.008

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  33 in total

1.  Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.

Authors:  Hideki Fujii; Yuriko Yonekura; Yusuke Yamashita; Keiji Kono; Kentaro Nakai; Shunsuke Goto; Mikio Sugano; Sumie Goto; Ayako Fujieda; Yoshiharu Ito; Shinichi Nishi
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

Review 2.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Authors:  Ke Wang; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 8.237

3.  Protein-Bound Uremic Toxins and Immunity.

Authors:  Maria Teresa Rocchetti; Carmela Cosola; Elena Ranieri; Loreto Gesualdo
Journal:  Methods Mol Biol       Date:  2021

4.  Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Authors:  Xue-Sen Cao; Jun Chen; Jian-Zhou Zou; Yi-Hong Zhong; Jie Teng; Jun Ji; Zhang-Wei Chen; Zhong-Hua Liu; Bo Shen; Yu-Xin Nie; Wen-Lv Lv; Fang-Fang Xiang; Xiao Tan; Xiao-Qiang Ding
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

Review 5.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

6.  Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.

Authors:  Nina Queisser; Patricia I Oteiza; Samuel Link; Valentin Hey; Helga Stopper; Nicole Schupp
Journal:  Antioxid Redox Signal       Date:  2014-03-21       Impact factor: 8.401

Review 7.  Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

Authors:  Daniel Y Li; W H Wilson Tang
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

Review 8.  Oxidative stress in chronic kidney disease.

Authors:  Kristien Daenen; Asmin Andries; Djalila Mekahli; Ann Van Schepdael; François Jouret; Bert Bammens
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

Review 9.  Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.

Authors:  Jonathan D Ravid; Mohamed Hassan Kamel; Vipul C Chitalia
Journal:  Nat Rev Nephrol       Date:  2021-03-23       Impact factor: 28.314

Review 10.  Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.

Authors:  Anna Pieniazek; Joanna Bernasinska-Slomczewska; Lukasz Gwozdzinski
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.